ReviewEuropean journal of haematology2025

Advances and Challenges in Quizartinib-Based FLT3 Inhibition for Acute Myeloid Leukemia: Mechanisms of Resistance and Prospective Combination Therapies.

Antonella Bruzzese et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.